WATTON COREY MICHAEL sold 87.2% of their position (12.30K shares) of ZEVRA THERAPEUTICS, INC. on the open market
Open‑market sale worth $138.4K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/12/2026ACC: 0001434647-26-000070
Director
Since Apr 2023
-12.30K
Net shares
Net seller
$138.4K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
12.30K acquired · 24.60K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+12.30K
Price / share
$4.97
Trade value
$61.13K
% of position
683.3%
8/10/2026
1.80K→14.10K
Common Stock
Direct
Shares
−12.30K
Price / share
$11.25
Trade value
$138.38K
% of position
87.2%
8/10/2026
14.10K→1.80K
Total
Net shares
+0.00
Net value
-$77.25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/10/2026 | M · Option Exercise | +12.30K | $4.97 | $61.13K | 683.3% | 1.80K | 14.10K |
| Common Stock Direct | 8/10/2026 | S · Sale | −12.30K | $11.25 | $138.38K | 87.2% | 14.10K | 1.80K |
| Total | +0.00 | -$77.25K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
12.30K shares
Shares
−12.30K
Strike price
4.97
Held after
46.50K
Exercisable
—
8/10/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock12.30K shares | 8/10/2026 | M · Option Exercise | −12.30K | 4.97 | — | 46.50K |